Osiris Therapeutics, Inc. (OSIR) and NuVasive, Inc. (NUVA) Enter into Definitive Agreement for Osteocel(R) for Up to $85 Million in Upfront and Milestone Payments
5/9/2008
More...
|
FDA Delays Decision on Adolor Corporation (ADLR), GlaxoSmithKline (GSK) Bowel Drug
5/9/2008
More...
|
Enzo Biochem (ENZ) Acquires BIOMOL International, Further Expanding Its Life Sciences Operations
5/9/2008
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.
5/9/2008
More...
|
Applera Corporation (ABI)s Board of Directors Formally Approves Proposed Separation of Its Celera Business
5/9/2008
More...
|
Otsuka Pharmaceutical Co., Ltd., Bristol-Myers Squibb Company (BMY) ABILIFY(R) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia
5/9/2008
More...
|
FDA Grants Priority Review of Talecris Biotherapeutics's Gamunex(R) as a Treatment for Neurological Disorder CIDP
5/9/2008
More...
|
Bristol-Myers Squibb Company (BMY) CEO Buys 100,000 Shares
5/9/2008
More...
|
Celator Pharmaceuticals, Inc. Announces Appointment of Scott Jackson as CEO
5/9/2008
More...
|
Roche (RHHBY) New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients - Fifth International Phase III Study Shows Positive Results with X-ray Data
5/9/2008
More...
|
ZIOPHARM, Inc. Receives FDA Orphan Drug Designation for Palifosfamide (ZIO-201) in the Treatment of Soft Tissue Sarcoma
5/9/2008
More...
|
Biovail Corporation (BVF) Announces New Strategic Focus; Close Plants and Take Charges
5/8/2008
More...
|
FDA Approves Eli Lilly and Company (LLY)'s Strattera(R) for Maintenance of ADHD in Children and Adolescents
5/8/2008
More...
|
Osiris Therapeutics, Inc. (OSIR) Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
5/8/2008
More...
|
FDA Advisory Committee Votes in Favor of Approval for Eisai Company, Ltd. (ESALY.PK)'s Fospropofol Disodium Injection
5/8/2008
More...
|